AutoScreenTM Framework
Home > AutoScreenTM Framework
The AutoScreenTM Framework
The AutoScreen™ Framework is our end-to-end participant acquisition and prescreening system built specifically for Phase 2-3 autoimmune clinical trials. It combines MHRA-compliant digital recruitment funnels, real-time medical prescreening, and automated coordinator handoff to deliver a consistent flow of qualified, study-ready participants to UK research sites. Instead of relying on slow, traditional referral channels, AutoScreenTM turns targeted digital outreach into predictable enrolment momentum, without increasing site workload.
Phase 1 : Targeted Digital Outreach
MHRA-compliant Meta campaigns are deployed to identify and engage individuals with autoimmune conditions who may meet preliminary study criteria. All ad creatives and messaging are designed to remain clinically accurate, ethically appropriate, and fully aligned with regulatory expectations.
Phase 2 : Custom Landing Page + VSL
Participants are directed to a dedicated study landing page containing clear, protocol-aligned information and a concise video study overview (VSL). This hub is designed to orient potential participants, set expectations, and guide them into the structured eligibility pathway.
Phase 3 : AutoScreenTM Eligibility Engine
A controlled prescreening workflow applies real-time inclusion and exclusion logic directly mapped to the protocol. This ensures that only individuals who meet essential clinical criteria progress, while non-eligible individuals are filtered out early in the process.
Phase 4 : Engagement Cycle
Eligible and provisionally eligible individuals enter an AI automated engagement sequence that reinforces study details, clarifies next steps, and reduces pre-visit attrition. Partially eligible candidates (e.g., missing data, borderline criteria) are automatically tagged for coordinator-led manual follow-up, ensuring no viable participant is lost.
Phase 5 : Coordinator Handoff
Validated participant data and prescreen outcomes are securely transmitted to the research site in a structured, coordinator-ready format. This enables efficient prioritisation, reduces administrative load, and accelerates enrolment of high-quality candidates.
Full CRM & Real-Time Pipeline Tracking
We provide research sites with full visibility into every patient moving through the recruitment pathway. Your dedicated CRM pipeline displays each participant’s status—from initial outreach and prescreen responses to follow-up engagement and coordinator handoff, ensuring nothing is missed.
All interactions, eligibility outcomes, and communication logs are captured in real time, allowing coordinators to prioritise candidates efficiently and maintain complete oversight of the enrolment process.
Data Tracking and Transaparent Reporting
We monitor every stage of the recruitment process using structured, protocol-aligned data capture. Key performance metrics—including outreach efficiency, eligibility pass-through rates, engagement patterns, and prescreen outcomes are tracked continuously to give sites a clear understanding of recruitment performance.
Sites receive regular, clinically relevant reports that highlight trends, bottlenecks, and projected enrolment velocity. This ensures full transparency, informed decision-making, and the ability to proactively adjust strategies to keep enrolment on pace.
© Copyright 2025. RH Clinical. All rights reserved.
We’re on a mission to help autoimmune clinical trials reach the patients who need them, by making site-level recruitment smarter, faster, and more efficient.